Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07272629 · ClinicalTrials.gov registry record · Phase 1
A Study to Evaluate the Effect of Single Oral Dose of Balinatunfib on Cardiac Repolarization in Healthy Adult Participants.
A Phase 1 study of Healthy Volunteers and Cardiac Repolarization, sponsored by Sanofi.
- Recruiting
- Registry status
- Phase 1
- Development phase
- 44
- Enrollment target
- 2
- Study locations
NCT07272629: Recruiting Phase 1 study of Healthy Volunteers and Cardiac Repolarization, sponsored by Sanofi.
NCT07272629 is a Phase 1 study of Healthy Volunteers and Cardiac Repolarization that is actively recruiting participants, run by Sanofi. The registered enrollment target is 44 participants, below the 482-participant average among 283 other Healthy Volunteers trials with a reported enrollment target (91% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07272629, a Phase 1 study of Healthy Volunteers and Cardiac Repolarization, is actively recruiting participants, sponsored by Sanofi.
- RECRUITING
- Registry status
- Phase 1
- Development phase
- 44 participants
- Enrollment target
- 2
- Study locations
Study Summary
This is a Phase 1, multicenter, randomized, double-blind, double-dummy, single dose, placebo- and positive-controlled, 4-sequence, 4-treatment, 4-period crossover study.
Conditions Studied
Interventions
- DRUG Placebo
- DRUG Balinatunfib
- DRUG Moxifloxacin
Study Locations (2)
Texas
- FORTREA CLINICAL RESEARCH UNIT INC- Site Number : 8400002 - Dallas
Wisconsin
- FORTREA CLINICAL RESEARCH UNIT INC- Site Number : 8400001 - Madison
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 44 participants |
| Start Date | 2025-12-04 |
| Est. Completion | 2026-04-27 |
| Phase | Phase 1 |
What NCT07272629 shows while recruiting
NCT07272629 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 44 participants, a relatively small participant target, below the 482-participant average among 283 other Healthy Volunteers trials with a reported enrollment target (91% lower).
The record links to 2 conditions, with Healthy Volunteers appearing as the primary indexed condition, and to 3 interventions - of which Placebo is the first listed.
NCT07272629 reports a single indexed study location in Texas, Wisconsin.
Frequently Asked Questions
What is clinical trial NCT07272629 about?
NCT07272629 is a clinical study titled "A Study to Evaluate the Effect of Single Oral Dose of Balinatunfib on Cardiac Repolarization in Healthy Adult Participants.". This is a Phase 1, multicenter, randomized, double-blind, double-dummy, single dose, placebo- and positive-controlled, 4-sequence, 4-treatment, 4-period crossover study.
What is the current status of trial NCT07272629?
This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 44 participants. The study started on 2025-12-04. Estimated completion is 2026-04-27.
What conditions does trial NCT07272629 study?
This clinical trial studies the following conditions: Healthy Volunteers, Cardiac Repolarization.
What interventions are being tested in trial NCT07272629?
The interventions under investigation include: Placebo (DRUG), Balinatunfib (DRUG), Moxifloxacin (DRUG).
Who is sponsoring clinical trial NCT07272629?
This trial is sponsored by Sanofi, which has 713 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07272629 being conducted?
This trial has 2 study locations across Texas, Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Healthy Volunteers
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07272629's enrollment target sits among peer trials
44 148th of 283 higher than 135 of 283 other Healthy Volunteers trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Healthy Volunteers trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Research Study to Evaluate the Safety of NNC4004-0002 When Given to Participants With Asymptomatic Hyperuricemia
RECRUITING · Phase 1
-
A Phase 1 Study to Evaluate the Safety and Pharmacokinetics of ABBV-243 in Healthy Adults.
RECRUITING · Phase 1
-
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Immunogenicity of ABBV-277 in Healthy Adult Participants
RECRUITING · Phase 1
-
Classroom Break, Cognition, and Fitness in Elementary School Children
RECRUITING · Phase 1
-
A Study to Assess the Relative Bioavailability of BMS-986435 and Food Effect on the BMS-986435 in Healthy Adult Participants
RECRUITING · Phase 1
-
A Study to Determine the Metabolism and Excretion of [14C]E2086 in Healthy Male Participants
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02323945 · 44 participants · NA
Effects of Breathing Mild Bouts of Low Oxygen on Limb Mobility After Spinal Injury
- NCT03093909 · 44 participants · Phase 1
Study of Aerosol Gemcitabine in Patients With Solid Tumors and Pulmonary Metastases
- NCT03104491 · 44 participants · Phase 1
Inotuzumab Ozogamicin Post-Transplant For Acute Lymphocytic Leukemia
- NCT03781765 · 44 participants · Phase 4
Stimulant vs. Non-stimulant Treatments and Reward Processing in Drug-naive Youth at SUD Risk
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI